Voices:

Patients and advocacy groups are needed to join with traditional stakeholders such as healthcare workers, payors, administrators, and regulatory authorities to maximize engagement across the array of voices needed to facilitate the uptake of innovations.

Venues:

Innovations in the assessment and management of health and disease will require new approaches to blurring the boundary between traditional healthcare settings, the workplace, and the home.

Tools:

New sources of data such as those acquired by wearable sensors during routine activities outside a medical facility, electronic health data from routine clinical care, and findings from transactions such as purchases will add to the phenotype of individuals. Data from these new sources will require AI approaches to understand how they identify patterns of health and disease and new approaches to prevention and treatment.

Partners:

Innovation along the discovery to delivery continuum will require new partners to develop novel laboratory tools and measurement methods, a strong network of academic and industry efforts, and incorporation of novel stakeholders not traditionally considered part of the healthcare system.